A new analysis has provided a comprehensive comparison of scores designed to predict which women with oestrogen-receptor positive breast cancer are at high risk of recurrence beyond five years after diagnosis, and may benefit from prolonged endocrine treatment. The promising new findings will like

Accurate, Rapid, Cost-Effective Blood Test Aims to Confirm True Negative Findings While Halving the Rate of False Negative Mammography Results Eventus Diagnostics, Inc. (EventusDx) have announced that it has received CE mark designation for its Octava PinkTM breast cancer test intended for confirma

A new blood test for women with breast cancer could identify more women who will benefit from the targeted treatment Herceptin without the need for uncomfortable biopsies. The new 'liquid biopsy' uses cutting-edge genetic techniques to detect breast cancer DNA in the bloodstream, and was developed

A Big-Data analysis that integrates three large sets of genomic data available through The Cancer Genome Atlas has identified 37 RNA molecules that might predict survival in patients with the most common form of breast cancer. The study by researchers at the Ohio State University Comprehensive Can

Study finds hundreds of lives could be prolonged if women in poorer areas were diagnosed with breast cancer at same stage as those in affluent areas Hundreds of women with breast cancer living in England's most deprived areas would have better survival rates if they were diagnosed at the same stag

A team of student researchers and their professors from 20 laboratories around the country have gotten a new view of cancer cells. The work could shed light on the transforming physical properties of these cells as they metastasize, said Jack R. Staunton, a Ph.D. candidate at Arizona State Universit

Drinking coffee could decrease the risk of breast cancer recurring in patients taking the widely used drug Tamoxifen, a study at Lund University in Sweden has found. Patients who took the pill, along with two or more cups of coffee daily, reported less than half the rate of cancer recurrence, compar

Young women with breast cancer who experience a longer treatment delay time (TDT) have significantly decreased survival time compared with those with a shorter TDT, especially African-American women, those with public or no insurance, and those with low socioeconomic status, according to a report pu

In a study reported in the resident's forum, Linda Adepoju, M.D., of University of Toledo Medical Center, Ohio, and colleagues suggest that tumor size, cancer stage, and Medicaid insurance were predictors of undergoing a mastectomy to treat breast cancer. (Online First) A total of 1,539 women with

Tamoxifen is a time-honored breast cancer drug used to treat millions of women with early-stage and less-aggressive disease, and now a University of Rochester Medical Center team has shown how to exploit tamoxifen's secondary activities so that it might work on more aggressive breast cancer. The res